GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving ...

Short interest in Emergent BioSolutions Inc (NYSE:EBS) increased during the last reporting period, rising from 6.93M to 7.09M. This put 15.91% of the company's publicly available shares short.

Q4 2024 Earnings Call Transcript March 3, 2025 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.05, ...

During the last three months, 4 analysts shared their evaluations of Emergent BioSolutions EBS, revealing diverse outlooks from bullish to bearish. The following table provides a quick overview of ...

I am broadly interested in understanding emergent phenomena, especially (but not exclusively) in quantum systems. I have worked on a broad range of problems (and my interests are ever shifting, so ...

Co-author Baldacchino added: “The emergent curriculum evolves and emerges from children’s interests. It’s a flexible approach directed by children’s ideas with the guidance of their educators.

Welcome to Emergent BioSolutions Inc. Fourth Quarter ... In the US, the public interest channel is backed by over $50 billion in opioid settlement funds from large pharma companies that are ...